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IMMEDIATE EFFECTS OF BALLOON VALVOTOMY ON 
DEPRESSED LV PERFORMANCE IN MITRAL STENOSIS: 
IS IT ABNORMAL LOADING OR A MYOCARDLAL FACTOR? 
, Martin Bcrk, Shirley Middlemost, 
Rafiqut Essop, John Skoularigis, Pinhas Sarvzli, 
Baragwanatb Hospital, Johannesburg, South Africa 
LV dysfunction defined as ejection fraction 4.60 was detected in 
13/17 patients with mitral stenosis undergoing successful balloon 
mitral valvotomy (BMV) that was not complicated by mitral 
reeumitation. In order to test the hypothesis that underfilling due to 
inhow’ obstruction accounted for d$ressed ejection performance in 
these 17 pts, we evaluated LV load and performance immediately 
before and after relief of inflow oba-uction by BMV. BMV 
increased mean valve area from 0.8 cm2 to 2.1 cmz, and mean LA 
prcssun declined from 18 mm Hg to 10 mm Hg. Preload measured 
as end-diastolic stress and end-diastolic volume was not different 
from controls, and did not increase @:=NS) with BMV (41 to 50 
kdyn/cmz mean, and 156 to 162 ml mean, respectively). LV 
afterload measured as end-systolic wall stress was higher than in 
controls, nnd did not declini (255 to 243 kdyn/cm2, +NS), nor did 
end-systolic volume (69 to 67 ml). The result was no significant 
(~4.054) improvement in ejection fraction (0.55 to 0.58 mean). A 
decrease in mean diastolic fiilinP period from 0.59 to 0.51 seconds 
may have blunted further improiebnent in preload and performance. 
Using a prelo;ld-corrected ejection fraction-afterload relationship 
(available in 14 patients), contractile performance was abnobmal in 
six patients pre- and in five post-BMV. Thus, relief of inflow 
obstruction did not immediately result in significant increases in 
either preload or ejection fraction. Although afterload did not 
immediately improve with BMV and contributed to depressed 
performance, excessive afterload alone did not account for 
depressed performance, which suggests the presence of a 
myocardial factor in rheumatic mitral stenosis. 
2:oo 
PREDICTION OF EFFECTIVENESS OF LONG TERM ,!I-BLOCKER 
THERAPY FOR DILATED CARDIOMYOPATHY FROM A HISTOPATHOLOGI- 
CAL VIEWPOINT 
Takahisa Yarada, klasatake Fukuna 
Kazuaki Kumagai, Akihiko Sakai. Nobuhiko Kondoh. Tetsuo 
Minamino, Noritake Hoki. Division of cardiology, Osaka 
Prefectural Hospital. Osaka, Japan 
To elucidate whether responders to long ter 
(8) therapy for dilated cardiomyopathy(DCM) 
predicted before starting B-therapy. a number of 
variables including histopathological parameters before 
administration of B were retrospecti 
between 10 good responders (C) in who 
assessed by echocardiography improved 10% or more 12 
months after B-therapy and poor ones (PI without such an 
improvement. Although there were no significant 
differences in age, sex. NYHA functional class, heart 
rate, blood pressure, left ventricular end-diastolic 
diameter, left ventricular end-systolic diameter and 
ejection fraction, Xfibrosis estimated by the point count 
methor on endocardial biopsy samples was significantly 
lower in C than in P(3.88+0.98 vs 9.752 2. 7O%:p<O. 05). 
which suggests that the iaproveaent would be 
expected in patients with less endoayocardial fibrosis. 
Moreover, when the type of fibrosis were classified into 
intercellular (ICI and interfascicular (IF) types dy the 
dominancy of counted points. IF/IC were 8/2 in C arid l/9 
in P(p<O. 01. sensitivity 0.89, specificity 0.82. 
predictive value 0.85). suggesting that B-t herapy would 
effecti ve in patients with IF type than 
those with IC type. These findings indicate that 
Xfibrosis and fibrosis type might be i 
for prediction of effectiveness of B-therapy. 
3:lS 2:15 
POST-OPERATIVE CHANGES IN LEFT VENTRICULAR 
PERFORMANCE: A ‘COMPARISON OF ISOLATED MITRAL 
VALVE REPLACEMENT WITH COMBINED AORTIC AKD 
MITRAL VALVE REPLACEMENT 
Shirley Middlemost, 
Thomar Wiseabaugb, John Skoularigis, 
Piahk Sareli. Baragwaaath Hospital and 
University of the Witwatersraad, Johannesburg, SA. 
Changes in LV dimeasioas and performance following surger:’ :x 
combiaed aortic and mitral regurgitatioa have not beea defiaec. 70 
elucidate these changes and compare them with changes in LV 
function observed rf ter isolated mitral valve replacement we studied 
32 young patielats with active rheumatic carditis aad 
hemodyaamically -severe mitral regurgitation with or without 
coeriatcat aortic regurgitation uadergoiag isolated mitral (GP I, N = 
19) or combined mitral aad aortic valve replacemeat (GP II, N - 13). 
Age (1323 yrs), BSA (1.2&0.3cm2), functional class (3.StO.S) rod 
cardiothoracic ratio (0.65 f 0.06) for the 2 groups at baseline were 
comparable. LV ead diastolic ditneasioa (EDD), end systolic 
dimeasioa (ESD) and fractional shortening (FS) were measured pre 
rod 6 months post operatively using 2D targeted M-mode 
echocardiography. 
EDD (mm) 
ESD (mm) 
Fr (%6) 
GP I (N49) GPII (N=13) 
Pre op Post op Pre Op Post Op 
S7k7 46&7’ S7*9 43*7’ 
36&6 33&7 3826 28&B* 
38~6 29=8” 33ti 33&6 
pcO.05 GP I VI GP II (pre op). 
1) Preload rtductioa following surgery results in a significant post 
op decliae in EDD in both patieat groups 2) The known coatrastiag 
effects of mitral and aortic valve replacement on afterload result in 
an unchanged ESD in GPI aad a sigaificaatly reduced ESD in GP IL 
3) Thus, while FS falls sigaificaatly in GP I it is preserved in GP II. 
WHOLE 
John Radcliffe Hospital, Oxford, UKa” 
Angiotensin converting enzyme (ACE) inhibitors may improve 
survival in chronic heart failure by improving autonomic balance. We 
have used whole body [3H]norepinephrine (NE) kinetics to evaluate 
the short (48 hours) and medium term (6 weeks) effects of ACE 
inhibition wilh ramipril upon overall sympathetic activity in 21 pts 
with chronic heart failure (aged 6623 years) stabilized on diuretic 
treatment (69t6 mg furosemlde). Ar each visil NE kinetics were 
measured at.resI and a1 the same level Df supine bicycle exercise. 
In 8 placebo treated pts no changes in NE kinetics occurred, while in 
13 pts who received ramipril S-10 mg daily there was a decline in 
arterial plasma NE concentration and whole body NE spillover lo 
arterial plasma, both a1 rest and during submaximal exercise. This 
decline was more pronounced a1 6 weeks than a1 48 hours. Whole body 
NE clearance dlcl nol change in either group. 
Plasma NE @g/ml) NE Spillover (nglminlm2) 
Rest Exercise Rest Exercise 
Placebo -pre 215k31 480f48 240f32 561 zt65 
- 48 hrs 234i31 487i92 251f34 584f187 
-6 wks 197fll 553k11223Okl8 619k96 
Ramipril - pre 339k29 681 i48 385239 733246 
-48 hrs 315f37. 557~k64~ 354k43 728~114 
- 6 wks 303235’ 562k84’312t32’ 612i81’ 
’ PcO.05 versus pre-Ramipril 
We conclude that ACE inhibition with ramipril is associated with a 
decline in overall sympathelic tone in pts with chronic heart failure 
and that this effect is more prominent at 6 weeks than at 46 hrs. This 
may be relevant to the delayed clinical benefit of ACE inhiuition. 
